Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ananda Pharma is a publicly listed pharmaceutical company focused on developing CBD-based drugs for treating complex, chronic inflammatory pain conditions. They are currently conducting clinical trials, including ACTiON and ENDOCAN-1, to assess their patent-pending MRX1 drug candidate for conditions like Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis-associated pain. Ananda Pharma aims to create NHS-approv...
Ananda Pharma is a publicly listed pharmaceutical company focused on developing CBD-based drugs for treating complex, chronic inflammatory pain conditions. They are currently conducting clinical trials, including ACTiON and ENDOCAN-1, to assess their patent-pending MRX1 drug candidate for conditions like Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis-associated pain. Ananda Pharma aims to create NHS-approved and MHRA-licensed cannabinoid medicines to address unmet medical needs.

List your booth number for exhibitions, ask us